Last reviewed · How we verify

NCT05272930

The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis

Completed Last updated 23 February 2023
What this trial tests

trial testing Dienogest in Fibromyalgia in 61 participants. Completed in 30 April 2022.

Timeline
30 June 2021
Primary endpoint
15 March 2022
30 April 2022

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment61
Start date30 June 2021
Primary completion15 March 2022
Estimated completion30 April 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 40, female only, with Fibromyalgia or Endometriosis Ovary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis usually occurs during the reproductive period of women and poses a significant burden on quality of life and social costs. The estimated prevalence in premenopausal women is 10% in clinical studies and the frequency rises to 50% in symptomatic patients with pelvic pain and infertility. Observational studies in Europe estimated the prevalence to be 8-15 per 1000 people. Fibromyalgia is a common musculoskeletal chronic painful condition that may be accompanied by cognitive impairment, somatic symptoms, fatigue, and psychiatric symptoms. The population frequency is given as 20-80 per 1000 people. Fibromyalgia is most often diagnosed in women aged 20-55 years; prevalence increases with age and is associated with a higher prevalence of comorbidities, including endocrine and genitourinary disorders. Co-existance of endometriosis and fibromyalgia is a special entity that has not been enlightened in detal yet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dienogest

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing